Big things are happening in healthcare technology. Doximity, a top digital platform for doctors and medical professionals, has made a major move by acquiring Pathway Medical Inc. for $63 million. This deal is set to bring some of the most advanced AI tools in clinical care directly to healthcare providers. Combining their resources and expertise could change how medicine is practiced and improve patient outcomes.

What Makes Pathway Medical Special

Pathway Medical has spent the last seven years building one of the largest and most detailed medical datasets out there. Their team, led by physicians, created a comprehensive library that includes guidelines, drug info, and key trial data across many medical fields. This dataset is designed specifically for AI, helping algorithms recognize patterns and connections in complex medical research.

What really stands out is the accuracy of their AI models. In tests using the USMLE exam, which doctors take to get licensed, Pathway’s AI scored an impressive 96%. That high performance shows how reliable and well-developed their technology is. It’s not just big data; it’s data that works and helps make better clinical decisions.

What the Acquisition Means for Healthcare

By combining Pathway’s dataset with Doximity’s platform, millions of doctors and healthcare workers will get access to powerful AI tools right where they work. These tools can assist in diagnosis, treatment planning, and staying up-to-date with the latest medical research—all within the familiar systems they already use daily.

Pathway’s CEO, Jon Hershon, sees exciting opportunities ahead. He mentions the growing need for trusted evidence in medicine, along with the speed that AI can provide. With Doximity’s large user base—hundreds of thousands of registered users and many paying for premium services—their collaboration can make a real difference at critical moments in patient care.

The deal was finalized on July 29, 2025, with Doximity paying $26 million in cash and offering up to $37 million in equity grants. This move highlights Doximity’s focus on pushing healthcare tech forward and staying at the forefront of innovation.

Looking to the Future of Medical Innovation

This isn’t just a business deal—it’s a step toward a new era in healthcare. With Pathway now part of Doximity, the company aims to deliver better clinical tools that are more accurate and efficient. Healthcare professionals can make faster, more informed decisions that ultimately benefit patients.

Integrating these advanced AI capabilities promises not only improved accuracy but also greater efficiency in medical workflows. Doctors will be able to access trusted, evidence-based information at the moment they need it most, helping to improve health outcomes across the board.

Overall, this acquisition marks a big milestone for Doximity and the future of AI in medicine. By harnessing Pathway’s innovative datasets and AI models, the company is poised to transform clinical care and bring smarter, faster solutions to healthcare providers everywhere.

Inspired by

• https://ai-techpark.com/doximity-acquires-pathway-to-expand-ai-clinical-tools/